CDAI and DAS28-CRP agreement in rheumatoid arthritis: a tertiary-care cross-sectional study with exploratory machine learning
Year: 2026
Type: article
Study design: Observational Study
Abstract: Accurately evaluating disease activity in rheumatoid arthritis is crucial for guiding treatment decisions and monitoring patient outcomes. The Disease Activity Score based on 28 joints and C-reactive protein (DAS28-CRP) is widely used but requires laboratory testing and calculation, which can limit immediate use in resource-constrained settings. The Clinical Disease Activity Index (CDAI) offers a simpler alternative based entirely on clinical assessment. In this cross-sectional tertiary-care study, we examined same-visit agreement between CDAI and DAS28-CRP among 139 treated patients from Nepal and explored internally validated machine-learning (ML) models as a secondary exploratory analysis. CDAI distinguished remission/low from moderate/high DAS28-CRP activity with sensitivity of 88.1%, specificity of 97.2%, and ROC-AUC of 0.983. CDAI and DAS28-CRP were strongly correlated (Spearman \(\rho =0.955\) ; Pearson \(r=0.938\) ), and four-level disease-activity categories showed 71.9% observed agreement with substantial weighted agreement. Exploratory ML models showed high internal performance, but predictors overlapped substantially with DAS28-CRP, the sample was small, and these analyses should not be interpreted as evidence for routine clinical use. Discordant cases, particularly patients classified as remission/low activity by CDAI but moderate/high activity by DAS28-CRP, highlight the need for clinical judgment and laboratory assessment when indicated. These findings support CDAI as a practical assessment tool in this setting, while emphasizing that CDAI should complement rather than replace clinician assessment and that ML findings require external validation.
Source: Scientific Reports
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7237218835
